Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PRLB PROTO LABS, INC.
$77.96 -14.24% -12.95
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PRLB stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

PROTO LABS, INC. (PRLB)

Loading

Key Stats

Market cap. 2.2B
Enterprise value 2.0B
Trailing PE 70.96032
Forward PE 37.254166
PEG Ratio 0.7096032
Enterprise to EBITDA 26.964
Enterprise to revenue 3.565
Price to book MRQ 3.0920599
Price to sales TTM 3.815735

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 560.5M
EBITDA 78.0M
Diluted EPS TTM 1.26
Total Cash (MRQ) 142.8M
Current ratio (MRQ) 3.637
Operating Cash Flow (TTM) 78.5M

PRLB trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PRLB News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.